Search Results - "YEONG WOOK SONG"
-
1
Trial of Apremilast for Oral Ulcers in Behçet’s Syndrome
Published in The New England journal of medicine (14-11-2019)“…In a phase 3 trial involving patients with Behçet’s syndrome, the small-molecule phosphodiesterase 4 inhibitor apremilast reduced the number of oral ulcers and…”
Get full text
Journal Article -
2
Tofacitinib (CP‐690,550) in patients with rheumatoid arthritis receiving methotrexate: Twelve‐month data from a twenty‐four–month phase III randomized radiographic study
Published in Arthritis & rheumatology (Hoboken, N.J.) (01-03-2013)“…Objective The purpose of this 24‐month phase III study was to examine structural preservation with tofacitinib in patients with rheumatoid arthritis (RA) with…”
Get full text
Journal Article -
3
Genome-wide association studies identify IL23R - IL12RB2 and IL10 as Behçet's disease susceptibility loci
Published in Nature genetics (01-08-2010)“…Behçet's disease is a chronic systemic inflammatory disorder characterized by four major manifestations: recurrent ocular symptoms, oral and genital ulcers and…”
Get full text
Journal Article -
4
Genetic Association of a Gain‐of‐Function IFNGR1 Polymorphism and the Intergenic Region LNCAROD/DKK1 With Behçet’s Disease
Published in Arthritis & rheumatology (Hoboken, N.J.) (01-07-2021)“…Objective Behçet’s disease is a complex systemic inflammatory vasculitis of incompletely understood etiology. This study was undertaken to investigate genetic…”
Get full text
Journal Article -
5
Safety and effectiveness of peficitinib (ASP015K) in patients with rheumatoid arthritis: interim data (22.7 months mean peficitinib treatment) from a long-term, open-label extension study in Japan, Korea, and Taiwan
Published in Arthritis research & therapy (12-03-2020)“…Peficitinib (ASP015K), a novel oral Janus kinase inhibitor, has demonstrated efficacy and safety for the treatment of rheumatoid arthritis (RA) in randomized,…”
Get full text
Journal Article -
6
CCL3L3-null status is associated with susceptibility to systemic lupus erythematosus
Published in Scientific reports (27-09-2021)“…The correlation between copy number variation (CNV) and the susceptibility to systemic lupus erythematosus (SLE) has been reported for various immunity-related…”
Get full text
Journal Article -
7
Care for patients with rheumatic diseases during COVID‐19 pandemic: A position statement from APLAR
Published in International journal of rheumatic diseases (01-06-2020)Get full text
Journal Article -
8
The effect of 24-week belimumab treatment withdrawal followed by treatment restart in patients with SLE: an open-label, non-randomised 52-week study
Published in Arthritis research & therapy (16-02-2022)“…Treatment goals for patients with systemic lupus erythematosus (SLE) include minimising disease activity and reducing the risk of flares. Although belimumab is…”
Get full text
Journal Article -
9
Rheumatology in East Asia
Published in Arthritis research & therapy (23-03-2018)“…Europe and North America have been leaders in rheumatology for many years. However, for more than a decade now the East Asian region has been catching up…”
Get full text
Journal Article -
10
Sex-specific analysis in Behçet's disease reveals higher genetic risk in male patients
Published in Journal of autoimmunity (01-10-2022)“…Behçet's disease tends to be more severe in men than women. This study was undertaken to investigate sex-specific genetic effects in Behçet's disease. A total…”
Get full text
Journal Article -
11
Patients' Experience of Myositis and Further Validation of a Myositis-specific Patient Reported Outcome Measure - Establishing Core Domains and Expanding Patient Input on Clinical Assessment in Myositis. Report from OMERACT 12
Published in Journal of rheumatology (01-12-2015)“…The Outcome Measures in Rheumatology (OMERACT) myositis working group was established to examine patient-reported outcomes (PRO) as well as to validate…”
Get full text
Journal Article -
12
Efficacy and safety of intravenous belimumab in a subgroup of South Korean patients with systemic lupus erythematosus enrolled into a Phase 3, randomized, placebo‐controlled trial in North East Asia
Published in International journal of rheumatic diseases (01-01-2024)“…Aim This post hoc analysis evaluated the efficacy and safety of intravenous belimumab 10 mg/kg in the South Korean subgroup of patients with systemic lupus…”
Get full text
Journal Article -
13
Circulating TNF-like protein 1A (TL1A) is elevated early in rheumatoid arthritis and depends on TNF
Published in Arthritis research & therapy (07-05-2020)“…The tumor necrosis factor (TNF) superfamily cytokine TNF-like protein 1A (TL1A) and its receptor DR3 are essential for diverse animal models of autoimmune…”
Get full text
Journal Article -
14
Efficacy and safety of tocilizumab in Korean patients with active rheumatoid arthritis
Published in The Korean journal of internal medicine (01-07-2019)“…To investigate the efficacy and safety of tocilizumab (TCZ) humanized anti-interleukin-6 receptor monoclonal antibody, in Korean patients with active…”
Get full text
Journal Article -
15
Comparison of radioimmunoprecipitation versus antigen-specific assays for identification of myositis-specific autoantibodies in dermatomyositis patients
Published in Modern rheumatology (01-11-2014)“…Abstract Background. To confirm the antigen specificities of autoantibodies that precipitate 140-kDa (anti-p140) or 155/140-kDa polypeptides (anti-p155/140)…”
Get full text
Journal Article -
16
Efficacy and Tolerability of GCSB-5 for Hand Osteoarthritis: A Randomized, Controlled Trial
Published in Clinical therapeutics (01-08-2016)“…Abstract Purpose The aim of this study was to investigate the efficacy and tolerability of GCSB-5, a mixture of 6 purified herbal extracts, in treating hand…”
Get full text
Journal Article -
17
The Efficacy of Diacerein in Hand Osteoarthritis: A Double-Blind, Randomized, Placebo-Controlled Study
Published in Clinical therapeutics (01-04-2013)“…Abstract Background Diacerein is a drug used in osteoarthritis (OA) that elicits an inhibitory effect on interleukin-1 and metalloproteases. Although diacerein…”
Get full text
Journal Article -
18
Impact of Infliximab Biosimilar CT-P13 Dose and Infusion Interval on Real-World Drug Survival and Effectiveness in Patients with Ankylosing Spondylitis
Published in Journal of clinical medicine (01-10-2021)“…CT-P13 is an infliximab biosimilar approved for indications including ankylosing spondylitis (AS); the approved maintenance regimen is 5 mg/kg infused every…”
Get full text
Journal Article -
19
Evaluation of Serum Matrix Metalloproteinase-3 as an Objective Indicator for the Disease Activity in Rheumatoid Arthritis Patients Treated With Methotrexate Versus Tocilizumab: 24-week Results From a Prospective Randomized Controlled Study
Published in Journal of rheumatic diseases (01-04-2022)“…Objective: This study aims to evaluate the change in serum metalloproteinase-3 (MMP-3) following the management of active rheumatoid arthritis (RA) and define…”
Get full text
Journal Article -
20
A Case of Overlap Syndrome of Systemic Sclerosis and Cryoglobulinemic Vasculitis With Central Nervous System Involvement
Published in Journal of rheumatic diseases (01-10-2021)“…Mixed cryoglobulinemic vasculitis (CV) is occasionally caused by autoimmune diseases including systemic sclerosis. Multiorgan involvement such as skin, kidney,…”
Get full text
Journal Article